Complicating autoimmune diseases in myasthenia gravis: a review
- PMID: 25915571
- PMCID: PMC4616023
- DOI: 10.3109/08916934.2015.1030614
Complicating autoimmune diseases in myasthenia gravis: a review
Abstract
Myasthenia gravis (MG) is a rare autoimmune disease of skeletal muscle endplates. MG subgroup is relevant for comorbidity, but usually not accounted for. MG patients have an increased risk for complicating autoimmune diseases, most commonly autoimmune thyroid disease, systemic lupus erythematosus and rheumatoid arthritis. In this review, we present concomitant autoimmune disorders associated with the different MG subgroups, and show how this influences treatment and prognosis. Concomitant MG should always be considered in patients with an autoimmune disorder and developing new neuromuscular weakness, fatigue or respiratory failure. When a second autoimmune disorder is suspected, MG should be included as a differential diagnosis.
Keywords: Autoimmune disease; comorbidity; myasthenia gravis.
References
-
- Zhang B., Tzartos J. S, Belimezi M, et al. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. Arch. Neurol. 2012;69:445–451. - PubMed
-
- Gilhus N. E. Autoimmune myasthenia gravis. Expert Rev. Neurother. 2009;9:351–358. - PubMed
-
- Keesey J. C. Clinical evaluation and management of myasthenia gravis. Muscle Nerve. 2004;29:484–505. - PubMed
-
- Grob D., Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve. 2008;37:141–149. - PubMed
-
- Jacob S., Viegas S, Lashley D, Hilton-Jones D. Myasthenia gravis and other neuromuscular junction disorders. Pract. Neurol. 2009;9:364–371. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical